Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.26 trillion and total revenue of $114.72 billion.
Market Cap
1.26T
Revenue
114.72B
Profits
-40.36B
PE Ratio
n/a
Profit Margin
-35.18%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.68B | -0.17% | 1,015,026 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.10B | 0.46% | 741,412 | 15.53B |
| 3 | ARGX | argenx SE | 54.32B | 0.85% | 227,099 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 42.05B | 0.26% | 1,747,550 | - |
| 5 | ONC | BeOne Medicines AG | 37.50B | 0.69% | 279,838 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 32.81B | -0.85% | 2,441,289 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 28.92B | -5.51% | 2,274,709 | 4.80B |
| 8 | INSM | Insmed Incorporated | 28.73B | 33.86% | 12,037,245 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.26B | 1.50% | 8,248,285 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.00B | -1.19% | 2,390,296 | 5.82B |
| 11 | BNTX | BioNTech SE | 22.91B | -1.07% | 1,349,828 | 3.03B |
| 12 | MRNA | Moderna, Inc. | 21.50B | -4.27% | 5,642,150 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.76B | 1.95% | 5,234,323 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 16.66B | -1.88% | 833,863 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 16.47B | 2.31% | 629,754 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.19B | 0.99% | 1,221,356 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.12B | -7.94% | 5,410,766 | 2.44B |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.12B | -1.24% | 1,051,268 | 669.50M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.88B | 2.59% | 3,452,610 | 3.41B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.79B | -0.73% | 296,763 | 1.28B |
| 21 | CORT | Corcept Therapeutics Incorporated | 11.67B | -2.48% | 761,759 | 830.81M |
| 22 | TECH | Bio-Techne Corporation | 11.20B | -0.14% | 2,314,975 | 1.21B |
| 23 | CYTK | Cytokinetics, Incorporated | 11.05B | 3.20% | 2,523,490 | 67.67M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.95B | 3.68% | 1,076,002 | 5.67M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.81B | -1.28% | 397,147 | 708.24M |
| 26 | SMMT | Summit Therapeutics Inc. | 10.80B | 0.07% | 2,486,898 | - |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 10.32B | 15.95% | 1,507,069 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 10.17B | 2.60% | 2,704,018 | 1.66B |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.10B | 0.19% | 1,226,156 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 9.55B | -0.95% | 206,245 | 440.48M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.40B | 6.45% | 837,604 | 281.99M |
| 32 | SYRE | Spyre Therapeutics, Inc. | 9.12B | -0.89% | 454,361 | - |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.06B | 0.55% | 2,592,314 | 874.09M |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.90B | -0.10% | 2,096,227 | 42.16M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 8.85B | 0.88% | 510,851 | 105.00M |
| 36 | PCVX | Vaxcyte, Inc. | 8.50B | 5.31% | 1,284,488 | - |
| 37 | IMVT | Immunovant, Inc. | 8.20B | 1.17% | 917,989 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.76B | 0.97% | 7,786,658 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.72B | 1.26% | 796,450 | 239.92M |
| 40 | COGT | Cogent Biosciences, Inc. | 7.14B | -1.11% | 1,043,080 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.02B | -0.66% | 1,404,802 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.60B | 3.36% | 936,004 | 6.23M |
| 43 | ERAS | Erasca, Inc. | 6.34B | -1.88% | 2,427,085 | - |
| 44 | BLTE | Belite Bio, Inc | 6.32B | 1.37% | 133,416 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.31B | 9.96% | 1,617,161 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 6.24B | 0.39% | 434,952 | 7.50M |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 6.15B | -2.29% | 708,312 | 1.90M |
| 48 | DFTX | Definium Therapeutics, Inc. | 6.12B | 3.94% | 1,781,108 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | -0.80% | 393,774 | 290.54M |
| 50 | ORKA | Oruka Therapeutics, Inc. | 5.94B | 1.27% | 717,343 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.91B | 2.37% | 928,886 | 1.01B |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.89B | -0.49% | 2,866,844 | 591.33M |
| 53 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | -11.04% | 2,969,287 | 618.07M |
| 54 | CAI | Caris Life Sciences, Inc. | 5.65B | 21.58% | 11,272,920 | 989.61M |
| 55 | CRSP | CRISPR Therapeutics AG | 4.99B | -1.54% | 1,025,306 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.90B | -1.22% | 3,049,691 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.83B | -1.11% | 1,330,630 | - |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -1.27% | 1,451,203 | - |
| 59 | CELC | Celcuity Inc. | 4.55B | 0.36% | 569,612 | - |
| 60 | MANE | Veradermics, Incorporated | 4.54B | -2.42% | 457,093 | - |
| 61 | PBLS | Parabilis Medicines, Inc. | 4.53B | 1.95% | 263,692 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.30B | 0.30% | 2,430,348 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.21B | 0.95% | 1,679,201 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.19B | 0.73% | 1,317,574 | 56.99M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.92B | 1.27% | 3,049,179 | 3.60M |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.88B | -0.63% | 1,302,867 | - |
| 67 | GPCR | Structure Therapeutics Inc. | 3.74B | 4.14% | 335,485 | - |
| 68 | LEGN | Legend Biotech Corporation | 3.73B | 1.21% | 2,072,911 | 1.14B |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.59B | 2.11% | 67,601 | 803.79M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.56B | 2.27% | 2,696,679 | 117.00M |
| 71 | ALMS | Alumis Inc. | 3.54B | 2.51% | 653,454 | 8.40M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | 0.55% | 497,723 | 234.13M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -2.47% | 3,228,237 | 463.98M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.26B | 1.22% | 799,070 | 158.00K |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | 0.91% | 1,649,442 | 7.12M |
| 76 | MBX | MBX Biosciences, Inc. | 3.19B | -0.55% | 528,702 | - |
| 77 | QURE | uniQure N.V. | 3.15B | 2.53% | 1,268,111 | 18.67M |
| 78 | IRON | Disc Medicine, Inc. | 2.97B | -1.86% | 323,965 | - |
| 79 | IMNM | Immunome, Inc. | 2.92B | 1.18% | 832,002 | 4.02M |
| 80 | KOD | Kodiak Sciences Inc. | 2.83B | 4.10% | 638,864 | - |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 2.81B | 6.59% | 1,648,971 | 606.33M |
| 82 | IOVA | Iovance Biotherapeutics, Inc. | 2.77B | 43.09% | 73,430,649 | 324.97M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.72B | 0.66% | 1,168,544 | 156.04M |
| 84 | ATAI | AtaiBeckley Inc. | 2.66B | -0.55% | 4,418,306 | 3.49M |
| 85 | TRVI | Trevi Therapeutics, Inc. | 2.63B | -0.80% | 1,961,067 | - |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.62B | 0.40% | 805,118 | 36.77M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 3.57% | 1,960,488 | 717.00M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.49B | 6.83% | 4,288,547 | 71.13M |
| 89 | NKTR | Nektar Therapeutics | 2.48B | 0.49% | 403,459 | 55.63M |
| 90 | PGEN | Precigen, Inc. | 2.47B | 0.29% | 7,269,836 | 85.72M |
| 91 | KLRA | Kailera Therapeutics, Inc. | 2.44B | 3.85% | 178,305 | - |
| 92 | COAG | Hemab Therapeutics Holdings, Inc. | 2.44B | 4.13% | 278,762 | - |
| 93 | PHVS | Pharvaris N.V. | 2.41B | 3.08% | 570,441 | - |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 0.52% | 443,420 | - |
| 95 | ZLAB | Zai Lab Limited | 2.35B | 13.66% | 1,388,624 | 449.61M |
| 96 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | -1.35% | 3,769,705 | - |
| 97 | VERA | Vera Therapeutics, Inc. | 2.30B | 5.50% | 1,943,721 | - |
| 98 | VCEL | Vericel Corporation | 2.29B | -1.34% | 334,656 | 306.30M |
| 99 | ADMA | ADMA Biologics, Inc. | 2.27B | 8.64% | 5,613,565 | 512.28M |
| 100 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.33% | 843,086 | 959.90M |
| 101 | SION | Sionna Therapeutics, Inc. | 2.24B | 4.80% | 778,470 | - |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 0.01% | 95,332 | - |
| 103 | URGN | UroGen Pharma Ltd. | 2.23B | -1.79% | 1,216,994 | 188.73M |
| 104 | RAPP | Rapport Therapeutics, Inc. | 2.22B | 9.21% | 404,028 | 20.00M |
| 105 | BHVN | Biohaven Ltd. | 2.17B | 5.80% | 1,881,326 | - |
| 106 | NUVB | Nuvation Bio Inc. | 2.13B | -4.08% | 8,394,940 | 169.90M |
| 107 | GHRS | GH Research PLC | 2.10B | 5.18% | 486,521 | - |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 6.19% | 2,235,958 | 311.51M |
| 109 | STOK | Stoke Therapeutics, Inc. | 2.06B | - | 690,930 | 27.59M |
| 110 | MESO | Mesoblast Limited | 2.04B | 4.41% | 206,277 | 65.38M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 2.03B | 0.97% | 676,912 | 10.00M |
| 112 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | -1.86% | 2,106,288 | 7.47M |
| 113 | ABCL | AbCellera Biologics Inc. | 1.99B | 10.30% | 8,412,086 | 66.17M |
| 114 | NBTX | Nanobiotix S.A. | 1.94B | -4.74% | 128,450 | 38.27M |
| 115 | OCUL | Ocular Therapeutix, Inc. | 1.92B | 2.82% | 1,594,000 | 52.06M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | 0.73% | 1,188,198 | 98.34M |
| 117 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.29% | 1,725,200 | - |
| 118 | DMRA | Damora Therapeutics, Inc. | 1.84B | -3.08% | 696,394 | - |
| 119 | BRVE | Braveheart Bio, Inc. | 1.84B | 65.56% | 3,292,187 | - |
| 120 | KARD | Kardigan, Inc. | 1.82B | 0.54% | 249,165 | - |
| 121 | BCAX | Bicara Therapeutics Inc. | 1.81B | 6.26% | 704,022 | - |
| 122 | SEPN | Septerna, Inc. | 1.78B | 1.99% | 193,665 | 72.26M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.78B | -4.14% | 842,785 | 26.48M |
| 124 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | 5.34% | 5,241,243 | 1.97B |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.80% | 1,476,628 | 252.25M |
| 126 | IMCR | Immunocore Holdings plc | 1.75B | 3.63% | 572,932 | 430.78M |
| 127 | OBX | Obsidian Therapeutics, Inc. | 1.75B | -0.56% | 7,433 | - |
| 128 | LKFT | Lakefront Biotherapeutics NV | 1.71B | 0.19% | 361,336 | 1.20B |
| 129 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 0.32% | 14,794,378 | 54.86M |
| 130 | FTRE | Fortrea Holdings Inc. | 1.68B | -7.14% | 1,253,400 | 2.68B |
| 131 | ZYME | Zymeworks Inc. | 1.66B | -1.57% | 673,081 | 37.13M |
| 132 | ANAB | AnaptysBio, Inc. | 1.62B | -0.40% | 288,849 | 232.39M |
| 133 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | -2.50% | 1,473,449 | 208.78M |
| 134 | TYRA | Tyra Biosciences, Inc. | 1.61B | 4.86% | 776,076 | - |
| 135 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | -3.49% | 443,835 | - |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.58B | 2.59% | 231,105 | 20.00M |
| 137 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 2.46% | 4,341,322 | 59.51M |
| 138 | AAPG | Ascentage Pharma Group International | 1.57B | 1.36% | 3,901 | 82.08M |
| 139 | INVA | Innoviva, Inc. | 1.56B | 2.93% | 1,311,035 | 440.00M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.49B | 2.74% | 624,744 | - |
| 141 | XNCR | Xencor, Inc. | 1.49B | 0.81% | 996,650 | 104.97M |
| 142 | VIR | Vir Biotechnology, Inc. | 1.48B | -3.79% | 2,600,356 | 303.23M |
| 143 | SVRA | Savara Inc. | 1.47B | 5.08% | 1,007,705 | - |
| 144 | AVLN | Avalyn Pharma Inc. | 1.45B | 2.19% | 122,721 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 1.31% | 181,579 | - |
| 146 | ABSI | Absci Corporation | 1.41B | -1.19% | 1,769,467 | 1.84M |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.38B | 7.00% | 465,610 | - |
| 148 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | - | 887,615 | - |
| 149 | GLUE | Monte Rosa Therapeutics, Inc. | 1.33B | 0.64% | 1,082,142 | 28.73M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.32B | 2.49% | 1,112,752 | - |
| 151 | AKTS | Aktis Oncology, Inc. | 1.30B | 3.49% | 266,663 | 8.28M |
| 152 | IMTX | Immatics N.V. | 1.29B | -3.58% | 320,958 | 43.00M |
| 153 | VOR | Vor Biopharma Inc. | 1.28B | 6.42% | 735,452 | - |
| 154 | NVAX | Novavax, Inc. | 1.27B | 0.52% | 4,900,858 | 413.80M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.26B | 2.26% | 87,601 | 1.30M |
| 156 | MNKD | MannKind Corporation | 1.25B | -5.12% | 9,306,198 | 393.63M |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.24B | 3.36% | 106,560 | - |
| 158 | ARDX | Ardelyx, Inc. | 1.20B | -0.81% | 7,283,060 | 450.89M |
| 159 | WVE | Wave Life Sciences Ltd. | 1.19B | 1.52% | 1,663,270 | 65.37M |
| 160 | MGTX | MeiraGTx Holdings plc | 1.18B | 1.91% | 354,383 | 79.76M |
| 161 | DRTS | Alpha Tau Medical Ltd. | 1.17B | -2.04% | 379,166 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | -0.50% | 578,255 | - |
| 163 | APMD | Apnimed, Inc. | 1.11B | 5.17% | 300,817 | 120.15M |
| 164 | ANRO | Alto Neuroscience, Inc. | 1.11B | 1.57% | 421,151 | - |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | 1.93% | 595,342 | - |
| 166 | IVA | Inventiva S.A. | 1.10B | -1.27% | 380,655 | 7.94M |
| 167 | REPL | Replimune Group, Inc. | 1.08B | 8.71% | 7,281,332 | - |
| 168 | EYPT | EyePoint, Inc. | 1.08B | 4.73% | 2,240,675 | 2.79M |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -3.67% | 4,890,832 | 41.47M |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 3.16% | 123,151 | 99.00K |
| 171 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 1.90% | 747,869 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 1.02B | -2.85% | 1,830,579 | - |
| 173 | GERN | Geron Corporation | 1.01B | -3.68% | 16,207,172 | 204.56M |
| 174 | AVTX | Avalo Therapeutics, Inc. | 989.29M | -0.74% | 596,211 | 59.00K |
| 175 | JANX | Janux Therapeutics, Inc. | 981.85M | 0.63% | 504,623 | 24.00M |
| 176 | OMER | Omeros Corporation | 951.74M | 3.95% | 841,023 | 9.89M |
| 177 | ANNX | Annexon, Inc. | 917.52M | 4.28% | 3,049,250 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 896.82M | -1.73% | 1,265,142 | 191.45M |
| 179 | TBPH | Theravance Biopharma, Inc. | 876.93M | 0.12% | 272,439 | 109.78M |
| 180 | ATTO | Attovia Therapeutics, Inc. | 876.93M | -6.94% | 413,195 | 1.35M |
| 181 | DSGN | Design Therapeutics, Inc. | 861.75M | 1.47% | 353,680 | - |
| 182 | SLDB | Solid Biosciences Inc. | 857.50M | -0.23% | 577,443 | - |
| 183 | AURA | Aura Biosciences, Inc. | 851.51M | 7.52% | 577,447 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 850.55M | -4.25% | 2,821,805 | 8.22M |
| 185 | DBVT | DBV Technologies S.A. | 829.98M | -3.51% | 1,019,567 | 5.04M |
| 186 | SGP | SpyGlass Pharma, Inc. | 827.48M | 4.52% | 76,591 | - |
| 187 | KURA | Kura Oncology, Inc. | 823.83M | 0.87% | 844,088 | 71.64M |
| 188 | MNPR | Monopar Therapeutics Inc. | 805.26M | 0.82% | 285,798 | - |
| 189 | CLYM | Climb Bio, Inc. | 801.65M | 12.27% | 1,425,218 | - |
| 190 | DRUG | Bright Minds Biosciences Inc. | 797.11M | 1.00% | 140,843 | - |
| 191 | CADL | Candel Therapeutics, Inc. | 775.20M | 1.15% | 1,297,199 | - |
| 192 | PHAR | Pharming Group N.V. | 771.24M | 1.59% | 3,735 | 366.48M |
| 193 | TENX | Tenax Therapeutics, Inc. | 762.42M | 1.99% | 1,191,883 | - |
| 194 | OCS | Oculis Holding AG | 747.60M | 2.57% | 264,908 | 1.40M |
| 195 | CTMX | CytomX Therapeutics, Inc. | 733.66M | 0.60% | 1,937,260 | 18.30M |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 732.62M | -3.11% | 480,872 | 276.79M |
| 197 | IMMX | Immix Biopharma, Inc. | 716.17M | 5.45% | 1,220,483 | - |
| 198 | GYRE | Gyre Therapeutics, Inc. | 713.53M | 2.73% | 49,091 | 117.05M |
| 199 | NGNE | Neurogene Inc. | 709.40M | -1.06% | 94,290 | 925.00K |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 703.34M | -2.01% | 186,960 | - |
| 201 | CBIO | Crescent Biopharma, Inc. | 703.22M | 4.19% | 151,348 | 11.88M |
| 202 | RGNX | REGENXBIO Inc. | 696.01M | 7.43% | 1,769,173 | 174.48M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 693.06M | 12.82% | 2,493,514 | 136.07M |
| 204 | HELP | Cybin Inc. | 688.02M | 5.41% | 3,619,370 | - |
| 205 | ALLO | Allogene Therapeutics, Inc. | 679.95M | 1.03% | 3,170,438 | 22.00K |
| 206 | ACHV | Achieve Life Sciences, Inc. | 672.42M | -1.65% | 571,891 | - |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 666.42M | 1.94% | 1,471,256 | 239.66M |
| 208 | AGMB | AgomAb Therapeutics NV | 664.85M | -5.73% | 38,633 | - |
| 209 | FTH | Faeth Therapeutics, Inc. | 631.06M | -0.45% | 205,729 | - |
| 210 | NVCT | Nuvectis Pharma, Inc. | 613.51M | -2.23% | 210,553 | - |
| 211 | MDXG | MiMedx Group, Inc. | 609.28M | 0.48% | 1,389,718 | 355.17M |
| 212 | MPLT | MapLight Therapeutics, Inc. | 602.19M | 2.79% | 476,984 | - |
| 213 | CRMD | CorMedix Inc. | 589.17M | 1.35% | 702,373 | 400.05M |
| 214 | ALT | Altimmune, Inc. | 585.37M | -0.66% | 3,977,253 | 36.00K |
| 215 | CTNM | Contineum Therapeutics, Inc. | 577.48M | 0.52% | 227,501 | - |
| 216 | TECX | Tectonic Therapeutic, Inc. | 570.23M | 2.23% | 91,969 | - |
| 217 | ARVN | Arvinas, Inc. | 567.55M | 3.33% | 2,580,578 | 316.70M |
| 218 | RLMD | Relmada Therapeutics, Inc. | 563.26M | -1.29% | 984,238 | - |
| 219 | ARTV | Artiva Biotherapeutics, Inc. | 562.65M | -0.09% | 321,545 | 251.00K |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 555.26M | -9.28% | 1,734,487 | 132.42M |
| 221 | ANL | Adlai Nortye Ltd. | 553.60M | 5.89% | 316,659 | 5.00M |
| 222 | SLN | Silence Therapeutics plc | 553.58M | 4.27% | 252,795 | 839.00K |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 551.51M | 2.63% | 297,341 | 88.24M |
| 224 | SPRY | ARS Pharmaceuticals, Inc. | 551.13M | 3.54% | 1,264,521 | 98.99M |
| 225 | STTK | Shattuck Labs, Inc. | 549.03M | -2.85% | 772,342 | 1.00M |
| 226 | ZURA | Zura Bio Limited | 542.44M | 1.24% | 569,733 | - |
| 227 | SGMT | Sagimet Biosciences Inc. | 539.71M | 1.16% | 1,465,727 | - |
| 228 | PRME | Prime Medicine, Inc. | 532.82M | -4.22% | 2,554,587 | 4.07M |
| 229 | AUTL | Autolus Therapeutics plc | 532.29M | 5.26% | 3,789,977 | 92.62M |
| 230 | VSTM | Verastem, Inc. | 519.33M | 0.68% | 2,189,432 | 87.53M |
| 231 | ASMB | Assembly Biosciences, Inc. | 509.19M | -0.34% | 100,058 | 71.10M |
| 232 | EIKN | Eikon Therapeutics, Inc. | 498.62M | -3.56% | 361,585 | - |
| 233 | PROK | ProKidney Corp. | 495.38M | -1.80% | 382,750 | 889.00K |
| 234 | OVID | Ovid Therapeutics Inc. | 494.60M | 1.15% | 1,294,431 | 7.12M |
| 235 | RZLT | Rezolute, Inc. | 490.99M | 0.43% | 924,923 | - |
| 236 | VALN | Valneva SE | 485.37M | -0.96% | 16,570 | 180.25M |
| 237 | QTTB | Q32 Bio Inc. | 482.18M | -1.76% | 604,433 | 53.74M |
| 238 | EVMN | Evommune, Inc. | 481.93M | 2.76% | 941,367 | 10.00M |
| 239 | SCTX | Scribe Therapeutics Inc. | 479.34M | 6.76% | 193,057 | 36.28M |
| 240 | KYTX | Kyverna Therapeutics, Inc. | 471.16M | 1.44% | 505,207 | - |
| 241 | IKT | Inhibikase Therapeutics, Inc. | 470.97M | 0.42% | 422,921 | 1.00 |
| 242 | PRLD | Prelude Therapeutics Incorporated | 464.15M | 3.08% | 242,340 | 16.72M |
| 243 | BNTC | Benitec Biopharma Inc. | 451.07M | 3.47% | 82,867 | - |
| 244 | CABA | Cabaletta Bio, Inc. | 450.03M | 1.85% | 2,742,286 | - |
| 245 | PRTA | Prothena Corporation plc | 449.19M | 1.06% | 418,616 | 54.53M |
| 246 | EDIT | Editas Medicine, Inc. | 445.04M | 5.45% | 3,429,289 | 47.01M |
| 247 | SLBT | SL Science Holding Limited | 441.24M | -2.50% | 35,644 | 3.27M |
| 248 | LRMR | Larimar Therapeutics, Inc. | 438.41M | 2.44% | 759,754 | - |
| 249 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.34M | 2.78% | 195,716 | - |
| 250 | VTVT | vTv Therapeutics Inc. | 429.49M | 0.64% | 139,959 | 36.84M |
| 251 | OCGN | Ocugen, Inc. | 419.77M | -3.13% | 5,560,881 | 4.58M |
| 252 | PBYI | Puma Biotechnology, Inc. | 413.30M | 1.63% | 539,151 | 231.27M |
| 253 | CCCC | C4 Therapeutics, Inc. | 402.46M | 0.55% | 1,823,778 | 34.86M |
| 254 | STRO | Sutro Biopharma, Inc. | 400.18M | -3.78% | 153,945 | 99.61M |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 399.34M | 5.05% | 245,254 | - |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 393.31M | 0.48% | 447,776 | 15.85M |
| 257 | ABEO | Abeona Therapeutics Inc. | 393.27M | 1.47% | 828,887 | 14.54M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 387.91M | 0.91% | 220,695 | 69.21M |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 386.55M | 1.14% | 2,119,565 | - |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 376.55M | 3.04% | 119,059 | 51.00M |
| 261 | UPB | Upstream Bio, Inc. | 373.87M | 1.93% | 427,165 | 3.32M |
| 262 | DMAC | DiaMedica Therapeutics Inc. | 364.79M | 1.50% | 76,664 | - |
| 263 | PALI | Palisade Bio, Inc. | 362.78M | -1.42% | 779,174 | - |
| 264 | CMPX | Compass Therapeutics, Inc. | 358.37M | 5.29% | 6,688,565 | 850.00K |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 357.27M | 2.25% | 1,463,825 | - |
| 266 | ZNTL | Zentalis Pharmaceuticals, Inc. | 355.93M | 1.01% | 701,819 | 26.87M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 348.21M | 5.65% | 362,691 | 27.00K |
| 268 | IPSC | Century Therapeutics, Inc. | 342.67M | -3.06% | 594,299 | 109.16M |
| 269 | VCRE | Vicore Pharma Holding AB (publ) | 340.56M | -4.82% | 564 | 370.61K |
| 270 | AGEN | Agenus Inc. | 335.19M | -3.73% | 2,455,447 | 123.87M |
| 271 | CUVL | Clinuvel Pharmaceuticals Limited | 332.38M | 3.45% | 2,867 | 64.24M |
| 272 | FHTX | Foghorn Therapeutics Inc. | 327.04M | 14.14% | 365,676 | 36.74M |
| 273 | OABI | OmniAb, Inc. | 324.74M | 10.34% | 700,782 | 38.46M |
| 274 | VNDA | Vanda Pharmaceuticals Inc. | 307.59M | 0.49% | 2,339,819 | 215.72M |
| 275 | IRD | Opus Genetics, Inc. | 307.14M | -1.59% | 681,111 | 9.86M |
| 276 | AVXL | Anavex Life Sciences Corp. | 303.96M | 2.50% | 856,158 | - |
| 277 | NMRA | Neumora Therapeutics, Inc. | 303.87M | 1.86% | 345,694 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 294.39M | 2.12% | 280,361 | 114.70K |
| 279 | FATE | Fate Therapeutics, Inc. | 290.23M | -4.23% | 2,227,298 | 6.32M |
| 280 | IMRX | Immuneering Corporation | 288.55M | 1.59% | 772,323 | - |
| 281 | FULC | Fulcrum Therapeutics, Inc. | 287.64M | - | 1,041,519 | 80.00M |
| 282 | TTRX | Turn Therapeutics Inc. | 286.26M | 1.91% | 100,561 | - |
| 283 | SLGL | Sol-Gel Technologies Ltd. | 284.08M | -1.25% | 86,128 | 18.47M |
| 284 | ALXO | ALX Oncology Holdings Inc. | 283.93M | 9.90% | 580,678 | - |
| 285 | LCTX | Lineage Cell Therapeutics, Inc. | 281.71M | -0.88% | 711,637 | 13.08M |
| 286 | BCYC | Bicycle Therapeutics plc | 277.15M | - | 225,050 | 61.21M |
| 287 | ADAG | Adagene Inc. | 273.54M | -2.13% | 306,532 | 7.67M |
| 288 | PRQR | ProQR Therapeutics N.V. | 268.13M | -3.55% | 1,247,984 | 15.73M |
| 289 | ELDN | Eledon Pharmaceuticals, Inc. | 267.47M | 0.58% | 655,126 | - |
| 290 | RNAC | Cartesian Therapeutics, Inc. | 257.38M | 4.91% | 105,580 | 1.48M |
| 291 | MGNX | MacroGenics, Inc. | 254.89M | 2.82% | 756,455 | 157.08M |
| 292 | IFRX | InflaRx N.V. | 253.34M | -2.82% | 538,685 | -11.54K |
| 293 | WHWK | Whitehawk Therapeutics, Inc. | 252.78M | 15.48% | 308,662 | 7.15M |
| 294 | SRZN | Surrozen, Inc. | 251.25M | -1.41% | 211,714 | 7.49M |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 248.50M | -1.66% | 149,131 | 32.72M |
| 296 | TRDA | Entrada Therapeutics, Inc. | 247.71M | -2.69% | 269,893 | 4.69M |
| 297 | CAPR | Capricor Therapeutics, Inc. | 242.07M | 6.36% | 3,212,514 | 11.13M |
| 298 | NAGE | Niagen Bioscience, Inc. | 241.05M | 2.70% | 702,943 | 129.08M |
| 299 | PYXS | Pyxis Oncology, Inc. | 237.58M | 19.81% | 1,395,538 | 13.86M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 233.67M | 12.22% | 654,838 | 3.93M |
| 301 | TARA | Protara Therapeutics, Inc. | 230.44M | 2.50% | 329,177 | - |
| 302 | ACIU | AC Immune SA | 230.15M | 1.31% | 70,313 | 21.67M |
| 303 | CNXU | Conexeu Sciences Inc. | 226.64M | -5.78% | 190,855 | - |
| 304 | ANTX | AN2 Therapeutics, Inc. | 218.98M | 4.11% | 207,235 | - |
| 305 | CGEN | Compugen Ltd. | 217.87M | 0.88% | 207,066 | 74.00M |
| 306 | GALT | Galectin Therapeutics Inc. | 212.06M | 4.21% | 510,959 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 211.16M | 6.50% | 386,630 | 15.01M |
| 308 | GLSI | Greenwich LifeSciences, Inc. | 209.02M | -1.04% | 87,607 | - |
| 309 | RNA | Atrium Therapeutics, Inc. | 207.15M | 3.15% | 193,100 | 36.68M |
| 310 | NERV | Minerva Neurosciences, Inc. | 206.85M | 2.07% | 269,791 | - |
| 311 | ALEC | Alector, Inc. | 203.18M | 22.82% | 5,704,430 | 13.86M |
| 312 | CLLS | Cellectis S.A. | 202.63M | -3.58% | 68,446 | 75.11M |
| 313 | IMUX | Immunic, Inc. | 198.06M | 3.78% | 145,944 | - |
| 314 | NBP | NovaBridge Biosciences | 196.60M | 3.66% | 156,402 | - |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 196.59M | - | 530,892 | 76.38M |
| 316 | CHRS | Coherus Oncology, Inc. | 195.13M | -12.76% | 3,721,726 | 50.94M |
| 317 | IVVD | Invivyd, Inc. | 194.15M | 9.03% | 3,265,251 | 55.87M |
| 318 | DTIL | Precision BioSciences, Inc. | 191.45M | -0.67% | 328,717 | 45.06M |
| 319 | HUMA | Humacyte, Inc. | 191.34M | -2.63% | 1,957,034 | 2.02M |
| 320 | VYGR | Voyager Therapeutics, Inc. | 189.12M | 0.97% | 421,033 | 34.46M |
| 321 | ACOG | Alpha Cognition Inc. | 188.78M | 1.76% | 15,084 | 10.83M |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.71M | 3.46% | 227,538 | 17.56M |
| 323 | MDWD | MediWound Ltd. | 183.53M | 0.63% | 33,202 | 14.48M |
| 324 | NGEN | NervGen Pharma Corp. | 183.03M | 2.38% | 343,555 | - |
| 325 | OTLK | Outlook Therapeutics, Inc. | 181.85M | -5.58% | 3,976,140 | 333.14K |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 180.46M | 1.78% | 157,974 | - |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 175.98M | -0.46% | 187,551 | 2.00M |
| 328 | KRRO | Korro Bio, Inc. | 174.80M | 5.39% | 173,149 | 2.38M |
| 329 | ARCT | Arcturus Therapeutics Holdings Inc. | 172.81M | -2.88% | 334,880 | 29.37M |
| 330 | ARMP | Armata Pharmaceuticals, Inc. | 172.54M | - | 103,857 | 5.20M |
| 331 | OKUR | OnKure Therapeutics, Inc. | 168.06M | -0.24% | 85,940 | - |
| 332 | PEPG | PepGen Inc. | 166.70M | 21.72% | 4,475,878 | - |
| 333 | YDES | YD Bio Limited | 166.24M | 5.07% | 20,084 | 510.36K |
| 334 | IPHA | Innate Pharma S.A. | 164.73M | 0.85% | 3,334 | 10.57M |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 164.68M | 1.79% | 228,244 | - |
| 336 | NKTX | Nkarta, Inc. | 163.84M | 4.09% | 698,925 | - |
| 337 | LENZ | LENZ Therapeutics, Inc. | 163.67M | -0.95% | 535,041 | 20.99M |
| 338 | CRBU | Caribou Biosciences, Inc. | 162.66M | 1.86% | 1,059,394 | 11.20M |
| 339 | MIST | Milestone Pharmaceuticals Inc. | 160.54M | 3.06% | 594,583 | 1.78M |
| 340 | AARD | Aardvark Therapeutics, Inc. | 159.26M | -2.93% | 63,087 | - |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 157.50M | -7.51% | 2,929,370 | 1.34M |
| 342 | MOLN | Molecular Partners AG | 150.03M | -2.64% | 723 | 856.30K |
| 343 | MENS | Jyong Biotech Ltd. | 149.95M | -1.46% | 39,821 | - |
| 344 | CNTN | Canton Strategic Holdings, Inc. | 143.45M | -2.11% | 314,715 | - |
| 345 | CBUS | Cibus, Inc. | 142.74M | -3.11% | 105,748 | 4.29M |
| 346 | INDP | Indaptus Therapeutics, Inc. | 141.55M | -6.02% | 247,812 | - |
| 347 | KZIA | Kazia Therapeutics Limited | 140.89M | 2.75% | 250,777 | 1.27M |
| 348 | ENTX | Entera Bio Ltd. | 139.00M | 0.36% | 387,932 | 42.00K |
| 349 | UNCY | Unicycive Therapeutics, Inc. | 138.33M | -3.44% | 565,913 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 137.89M | 0.46% | 552,244 | 233.00K |
| 351 | HURA | TuHURA Biosciences, Inc. | 134.69M | 1.20% | 88,207 | - |
| 352 | CDXS | Codexis, Inc. | 134.53M | 2.07% | 1,120,846 | 78.09M |
| 353 | EQ | Equillium, Inc. | 134.04M | -3.20% | 468,619 | 4.39M |
| 354 | NRXP | NRx Pharmaceuticals, Inc. | 129.50M | 1.15% | 552,115 | 2.29M |
| 355 | SPRB | Spruce Biosciences, Inc. | 127.76M | -0.41% | 39,416 | 697.00K |
| 356 | TLSA | Tiziana Life Sciences Ltd | 125.98M | -1.59% | 1,989,049 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 120.58M | - | 303,972 | - |
| 358 | SEER | Seer, Inc. | 120.41M | - | 381,376 | 15.17M |
| 359 | GNLX | Genelux Corporation | 119.90M | 7.57% | 209,639 | 8.00K |
| 360 | PMN | ProMIS Neurosciences, Inc. | 119.54M | -1.11% | 14,685 | - |
| 361 | VANI | Vivani Medical, Inc. | 117.28M | -1.45% | 53,036 | - |
| 362 | ANIX | Anixa Biosciences, Inc. | 116.70M | 0.59% | 106,469 | - |
| 363 | YARW | Yarrow Bioscience, Inc. | 116.58M | 10.44% | 18,495 | - |
| 364 | CUE | Cue Biopharma, Inc. | 113.45M | 1.35% | 151,063 | 32.73M |
| 365 | NAUT | Nautilus Biotechnology, Inc. | 112.76M | -4.72% | 1,038,925 | 190.00K |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 110.02M | 7.26% | 748,139 | 70.00M |
| 367 | GUTS | Fractyl Health, Inc. | 108.99M | 0.29% | 764,376 | 3.00K |
| 368 | COYA | Coya Therapeutics, Inc. | 107.43M | 0.66% | 249,792 | 7.94M |
| 369 | RANI | Rani Therapeutics Holdings, Inc. | 106.51M | 0.14% | 696,086 | 3.17M |
| 370 | PLYX | Polaryx Therapeutics, Inc. | 105.10M | -0.89% | 44,504 | - |
| 371 | PTHS | Pelthos Therapeutics Inc. | 102.36M | 3.19% | 75,781 | 27.70M |
| 372 | CGTX | Cognition Therapeutics, Inc. | 101.13M | 6.60% | 1,049,789 | - |
| 373 | ICCC | ImmuCell Corporation | 99.70M | 2.51% | 41,567 | 29.93M |
| 374 | KLRS | Kalaris Therapeutics, Inc. | 99.69M | - | 55,619 | - |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 95.91M | -0.63% | 579,204 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 95.55M | 0.43% | 555,327 | - |
| 377 | HRTX | Heron Therapeutics, Inc. | 94.45M | -1.15% | 1,712,621 | 150.71M |
| 378 | PYPD | PolyPid Ltd. | 92.23M | 4.57% | 137,172 | - |
| 379 | VRCA | Verrica Pharmaceuticals Inc. | 92.08M | -2.72% | 85,000 | 37.16M |
| 380 | FBIO | Fortress Biotech, Inc. | 92.02M | -0.72% | 651,385 | 66.16M |
| 381 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | - | 32,479 | 39.99K |
| 382 | BMEA | Biomea Fusion, Inc. | 90.37M | -0.79% | 434,763 | - |
| 383 | GOSS | Gossamer Bio, Inc. | 87.21M | 0.39% | 8,230,664 | 55.54M |
| 384 | MAIA | MAIA Biotechnology, Inc. | 86.34M | 1.43% | 347,413 | - |
| 385 | NRXS | NeurAxis, Inc. | 85.82M | 2.06% | 62,899 | 4.28M |
| 386 | RLYB | Rallybio Corporation | 85.78M | 0.31% | 27,116 | 646.00K |
| 387 | ACET | Adicet Bio, Inc. | 83.27M | -13.43% | 179,921 | - |
| 388 | OKYO | OKYO Pharma Limited | 80.56M | -2.23% | 109,498 | - |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | -0.85% | 19,649 | - |
| 390 | ATHE | Alterity Therapeutics Limited | 80.33M | 4.35% | 2,921 | 4.43M |
| 391 | ANVS | Annovis Bio, Inc. | 79.13M | -0.53% | 317,215 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 75.92M | -1.11% | 371,941 | - |
| 393 | ATRA | Atara Biotherapeutics, Inc. | 74.33M | -3.40% | 22,856 | 23.14M |
| 394 | INO | Inovio Pharmaceuticals, Inc. | 73.88M | -0.47% | 1,731,539 | 65.34K |
| 395 | ELTX | Elicio Therapeutics, Inc. | 73.64M | -1.57% | 216,670 | - |
| 396 | SPRO | Spero Therapeutics, Inc. | 73.53M | 0.79% | 974,677 | 61.19M |
| 397 | LONA | LeonaBio, Inc. | 73.36M | 3.91% | 4,083 | - |
| 398 | OSTX | OS Therapies Incorporated | 72.60M | 1.87% | 223,972 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 72.33M | 3.05% | 316,165 | - |
| 400 | CSBR | Champions Oncology, Inc. | 72.11M | -2.08% | 15,818 | 59.43M |
| 401 | ELOX | Eloxx Pharmaceuticals, Inc. | 71.48M | -0.95% | 20,528 | - |
| 402 | XBIT | XBiotech Inc. | 69.51M | 0.88% | 9,957 | - |
| 403 | ALPS | Alps Group Inc | 69.06M | 3.11% | 9,459 | 3.74M |
| 404 | IBIO | iBio, Inc. | 69.05M | -0.71% | 424,306 | 300.00K |
| 405 | CING | Cingulate Inc. | 68.02M | 2.23% | 96,690 | - |
| 406 | RNTX | Rein Therapeutics Inc. | 67.45M | 10.37% | 206,067 | - |
| 407 | MNOV | MediciNova, Inc. | 66.94M | 2.26% | 18,636 | 596.64K |
| 408 | CRDF | Cardiff Oncology, Inc. | 65.66M | 0.57% | 446,328 | 525.00K |
| 409 | PLRX | Pliant Therapeutics, Inc. | 65.02M | - | 639,016 | - |
| 410 | BOLD | Boundless Bio, Inc. | 63.79M | 1.43% | 295,717 | - |
| 411 | IMA | ImageneBio, Inc. | 63.50M | -2.09% | 21,629 | 800.00K |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 62.93M | 0.85% | 124,184 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 60.14M | -3.03% | 174,847 | 11.43M |
| 414 | DWTX | Dogwood Therapeutics, Inc. | 58.85M | -4.37% | 65,862 | - |
| 415 | XLO | Xilio Therapeutics, Inc. | 55.46M | 1.76% | 34,314 | 53.48M |
| 416 | INKT | MiNK Therapeutics, Inc. | 54.80M | -5.98% | 18,838 | - |
| 417 | RNXT | RenovoRx, Inc. | 51.86M | 8.49% | 693,592 | 1.49M |
| 418 | INMB | INmune Bio Inc. | 50.78M | 0.53% | 244,596 | 50.00K |
| 419 | TCRX | TScan Therapeutics, Inc. | 49.88M | -2.15% | 129,833 | 9.14M |
| 420 | TIL | Instil Bio, Inc. | 49.37M | 0.28% | 2,278 | - |
| 421 | ATYR | aTyr Pharma, Inc. | 49.22M | -5.10% | 582,645 | 190.00K |
| 422 | MREO | Mereo BioPharma Group plc | 48.83M | 0.79% | 658,016 | 500.00K |
| 423 | EDSA | Edesa Biotech, Inc. | 48.65M | -2.32% | 21,610 | - |
| 424 | IBO | Impact BioMedical Inc. | 48.61M | 4.84% | 30,675 | 39.00K |
| 425 | IMMP | Immutep Limited | 47.69M | -4.36% | 127,419 | 5.28M |
| 426 | EXOZ | eXoZymes, Inc. | 47.06M | -5.05% | 3,187 | -700.00 |
| 427 | VRXA | Veraxa Biotech AG | 46.90M | 2.20% | 65,249 | - |
| 428 | MGX | Metagenomi Therapeutics, Inc. | 46.68M | 2.06% | 146,313 | 22.33M |
| 429 | MCRB | Seres Therapeutics, Inc. | 46.68M | -3.79% | 80,158 | 1.88M |
| 430 | FLNA | Filana Therapeutics, Inc. | 46.33M | -0.08% | 422,724 | - |
| 431 | CNTX | Context Therapeutics Inc. | 46.31M | -27.27% | 4,337,284 | - |
| 432 | KPTI | Karyopharm Therapeutics Inc. | 44.19M | 2.09% | 1,189,059 | 151.12M |
| 433 | PDSB | PDS Biotechnology Corporation | 41.70M | 2.81% | 408,248 | - |
| 434 | HYPD | Hyperion DeFi, Inc. | 40.47M | -2.20% | 108,444 | 1.04M |
| 435 | RADX | Radiopharm Theranostics Limited | 39.67M | 0.36% | 33,894 | 10.86M |
| 436 | APLM | Apollomics, Inc. | 37.33M | -1.62% | 1,282 | 8.84M |
| 437 | CRVO | CervoMed Inc. | 37.33M | -1.78% | 624,513 | 2.09M |
| 438 | DYAI | Dyadic International, Inc. | 37.17M | 5.21% | 149,776 | 3.81M |
| 439 | VERU | Veru Inc. | 37.08M | -0.86% | 234,873 | 16.89M |
| 440 | BYSI | BeyondSpring Inc. | 35.77M | -10.84% | 54,476 | 1.88M |
| 441 | LTRN | Lantern Pharma Inc. | 35.47M | -0.71% | 35,891 | - |
| 442 | NTRB | Nutriband Inc. | 35.43M | 1.22% | 2,994 | 1.80M |
| 443 | SER | Serina Therapeutics, Inc. | 35.24M | 5.38% | 70,986 | 130.00K |
| 444 | GRCE | Grace Therapeutics, Inc. | 34.50M | -0.93% | 162,686 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 34.10M | 16.24% | 293,085 | 31.52M |
| 446 | ESLA | Estrella Immunopharma, Inc. | 32.10M | -0.15% | 13,933 | - |
| 447 | NNVC | NanoViricides, Inc. | 31.89M | -2.10% | 232,600 | - |
| 448 | ENLV | Enlivex Ltd. | 31.82M | -9.17% | 202,970 | - |
| 449 | LITS | Lite Strategy, Inc. | 31.61M | -2.76% | 117,558 | - |
| 450 | GNTA | Genenta Science S.p.A. | 30.90M | -1.50% | 55,452 | - |
| 451 | BCTX | BriaCell Therapeutics Corp. | 30.07M | -1.43% | 209,213 | - |
| 452 | ACTU | Actuate Therapeutics, Inc. | 29.43M | 8.85% | 186,955 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 28.89M | 2.29% | 26,031 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 28.26M | -0.14% | 1,521 | 7.44M |
| 455 | CVM | CEL-SCI Corporation | 28.14M | 5.92% | 268,655 | - |
| 456 | TVGN | Tevogen Inc. | 27.34M | -5.40% | 10,662 | - |
| 457 | ABVC | ABVC BioPharma, Inc. | 25.78M | 0.99% | 36,080 | 797.92K |
| 458 | IGC | IGC Pharma, Inc. | 25.01M | -0.83% | 312,912 | 1.11M |
| 459 | EVAX | Evaxion A/S | 24.98M | 0.50% | 6,545 | 7.53M |
| 460 | ATNM | Actinium Pharmaceuticals, Inc. | 24.69M | 5.12% | 98,940 | 90.00K |
| 461 | LGVN | Longeveron Inc. | 24.44M | 6.38% | 220,551 | 1.22M |
| 462 | BRNS | Barinthus Biotherapeutics plc | 23.08M | -0.89% | 199,569 | 14.97M |
| 463 | ALLR | Allarity Therapeutics, Inc. | 22.28M | 5.26% | 84,482 | 345.00K |
| 464 | PLRZ | Polyrizon Ltd. | 21.51M | 2.13% | 12,717 | - |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 21.08M | -1.27% | 29,707 | -13.27K |
| 466 | ATOS | Atossa Therapeutics, Inc. | 20.84M | 1.26% | 30,699 | - |
| 467 | GRDX | GridAI Technologies Corp. | 20.39M | 3.97% | 38,088 | - |
| 468 | NXTC | NextCure, Inc. | 20.19M | 6.48% | 187,131 | - |
| 469 | CLRB | Cellectar Biosciences, Inc. | 20.14M | - | 18,522 | - |
| 470 | QNTM | Quantum BioPharma Ltd. | 20.06M | 11.38% | 63,781 | - |
| 471 | DARE | Daré Bioscience, Inc. | 19.92M | -0.75% | 90,244 | 1.16M |
| 472 | COCP | Cocrystal Pharma, Inc. | 19.84M | 0.98% | 30,935 | 225.00K |
| 473 | CELU | Celularity Inc. | 19.77M | -6.97% | 25,839 | 26.55M |
| 474 | HOWL | Werewolf Therapeutics, Inc. | 19.58M | 0.20% | 97,323 | 21.00M |
| 475 | PLUR | Pluri Inc. | 19.53M | 4.02% | 5,142 | 1.08M |
| 476 | MRKR | Marker Therapeutics, Inc. | 18.67M | -1.75% | 30,387 | 3.55M |
| 477 | JSPR | Jasper Therapeutics, Inc. | 18.09M | -2.09% | 650,917 | - |
| 478 | NCEL | NewcelX Ltd. | 17.98M | -6.18% | 20,480 | - |
| 479 | NRSN | NeuroSense Therapeutics Ltd. | 17.78M | -7.16% | 234,023 | - |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 17.62M | -17.79% | 1,443,507 | 5.61M |
| 481 | LPCN | Lipocine Inc. | 17.56M | -1.84% | 37,012 | 1.57M |
| 482 | TVRD | Tvardi Therapeutics, Inc. | 17.36M | -7.50% | 519,931 | - |
| 483 | SKYE | Skye Bioscience, Inc. | 16.58M | -16.02% | 451,680 | - |
| 484 | OSRH | OSR Health, Inc. | 15.31M | -1.36% | 213,867 | 2.63M |
| 485 | PTN | Palatin Technologies, Inc. | 15.21M | -0.88% | 4,398 | 12.88M |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 15.10M | 0.28% | 4,906 | 1.90M |
| 487 | HIND | Vyome Holdings, Inc. | 15.02M | - | 1,911 | 152.72K |
| 488 | KTTA | Pasithea Therapeutics Corp. | 14.82M | -1.42% | 81,565 | - |
| 489 | TPST | Tempest Therapeutics, Inc. | 14.42M | -1.30% | 26,096 | - |
| 490 | MLEC | Moolec Science SA | 14.19M | -3.94% | 5,731 | 7.83M |
| 491 | AKTX | Akari Therapeutics, Plc | 14.14M | 7.73% | 11,036 | - |
| 492 | PASG | Passage Bio, Inc. | 14.11M | -4.56% | 5,320 | - |
| 493 | KALA | KALA BIO, Inc. | 13.70M | 5.11% | 47,717 | - |
| 494 | PBM | Psyence Biomedical Ltd. | 13.31M | 6.08% | 120,036 | - |
| 495 | BLRX | BioLineRx Ltd. | 13.05M | 2.69% | 15,644 | 1.40M |
| 496 | CMMB | Chemomab Therapeutics Ltd. | 12.96M | 2.86% | 119,235 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 12.31M | -0.93% | 52,154 | - |
| 498 | ICU | SeaStar Medical Holding Corporation | 12.26M | 0.99% | 47,816 | 1.44M |
| 499 | BIOT | Instinct Bio Technical Company Holdings Inc. | 11.81M | -4.54% | 489,479 | - |
| 500 | VTGN | Vistagen Therapeutics, Inc. | 11.65M | -4.44% | 3,573,708 | 1.27M |